DERM Journey Medical Corporation - Common Stock
NASDAQ · Pharmaceuticals · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 12, 2026
$6,61
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$4,3152-Wochen-Tief
$9,5052-Wochen-Hoch
P/E (TTM)
-30.0
EPS (TTM)
$-0.22
Umsatz (TTM)
$68M
Ihre Abzeichen
52W-Spanne
$4–$9
Analystenbewertung
BUY
Kursziel
$14
P/E
-30.0
ROE
-23.8%
Nettogewinnmarge
-9.0%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
DERM Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$6.61
P/E (TTM)
-30.0
EPS (TTM)
$-0.22
Umsatz (TTM)
$68M
ROE (TTM)
-23.8%
Verschuldungsgrad (MRQ)
0.8
52W-Spanne
$4–$9
DERM Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$62M2020-12-31 → 2025-12-31
EPS$-0.472020-12-31 → 2025-12-31
Freier Cashflow·2022-12-31 → 2024-12-31
Nettogewinnmarge-9.0%2021-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | DERM | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -30.05-Jahres-Durchschnitt ≈-10.3 | ≈-10.3 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | DERM | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -4.4%5-Jahres-Durchschnitt ≈-26.6% | ≈-26.6% | -590.8% | Spitzenklasse | |
| EBITDA Margin (EBITDA-Marge) | -13.2%5-Jahres-Durchschnitt ≈-26.6% | ≈-26.6% | -294.2% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | -8.9%5-Jahres-Durchschnitt ≈-31.2% | ≈-31.2% | 36.2% | Schwach | |
| Nettogewinnmarge (TTM) | -9.0%5-Jahres-Durchschnitt ≈-31.9% | ≈-31.9% | 14.4% | Unterdurchschnittlich | |
| ROA (TTM) | -6.8%5-Jahres-Durchschnitt ≈-24.8% | ≈-24.8% | -13.1% | Im Einklang | |
| ROE (TTM) | -23.8%5-Jahres-Durchschnitt ≈-117.4% | ≈-117.4% | -33.5% | Schwach | |
| ROIC | -14.4%5-Jahres-Durchschnitt ≈-42.5% | ≈-42.5% | -14.4% | Im Einklang |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | DERM | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 0.85-Jahres-Durchschnitt ≈1.0 | ≈1.0 | 1.1 | Geringe Verschuldung | |
| Liquiditätsgrad (MRQ) | 1.65-Jahres-Durchschnitt ≈1.5 | ≈1.5 | 4.7 | Geringe Liquidität | |
| Quick Ratio | 1.45-Jahres-Durchschnitt ≈1.1 | ≈1.1 | 1.5 | Geringe Liquidität | |
| Langfristige Schulden / Eigenkapital (MRQ) | 0.65-Jahres-Durchschnitt ≈1.0 | ≈1.0 | · | · |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | DERM | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 10.2%5-Jahres-Durchschnitt ≈9.4% | ≈9.4% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -5.7%5-Jahres-Durchschnitt ≈3.9% | ≈3.9% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 6.8% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | DERM | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.75-Jahres-Durchschnitt ≈0.8 | ≈0.8 | 0.4 | Spitzenklasse | |
| Inventory Turnover (Lagerumschlag) | 1.75-Jahres-Durchschnitt ≈2.8 | ≈2.8 | 0.8 | Spitzenklasse | |
| Receivables Turnover (Forderungsumschlag) | 3.15-Jahres-Durchschnitt ≈3.3 | ≈3.3 | 6.1 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$1.1M | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
3.7%
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 12, 2026 | $-0.01 | $-0.02 | 56.3% |
| 31. März 2026 | Mai 13, 2026 | $-0.08 | $-0.08 | -1.1% |
| 31. Dezember 2025 | $-0.05 | $-0.06 | 21.6% | |
| 30. September 2025 | $-0.09 | $-0.05 | -85.6% | |
| 30. Juni 2025 | $-0.16 | $-0.11 | -49.4% | |
| 31. März 2025 | $-0.18 | $-0.24 | 25.7% | |
| 31. Dezember 2024 | $-0.15 | $-0.36 | 58.3% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $62M | $56M | $79M | $74M | $63M | $45M | |
| Cost of Revenue | $21M | $21M | $23M | $31M | $32M | $15M | |
| R&D Expense | $480.0K | $10M | $8M | $11M | $3M | · | |
| SG&A Expense | $44M | $40M | $44M | $59M | $40M | $22M | |
| Operating Expenses | $70M | $70M | $81M | $101M | $98M | $37M | |
| Operating Income | $-8M | $-14M | $-2M | $-28M | $-35M | $8M | |
| Interest Expense | · | · | $2M | $2M | $7M | $698.0K | |
| Other Non-op | $-3M | $-934.0K | $-2M | $-2M | $-7M | $-698.0K | |
| Pretax Income | $-11M | $-15M | $-4M | $-30M | $-42M | $7M | |
| Income Tax | $60.0K | $61.0K | $221.0K | $63.0K | $2M | $2M | |
| Net Income | $-11M | $-15M | $-4M | $-30M | $-44M | $5M | |
| EPS (Basic) | $-0.47 | $-0.72 | $-0.21 | $-1.69 | $-4.32 | $0.58 | |
| EPS (Diluted) | $-0.47 | $-0.72 | $-0.21 | $-1.69 | $-4.32 | $0.49 | |
| Shares (Basic) | 24,497,973 | 20,431,400 | 18,232,422 | 17,531,274 | 10,189,844 | 9,135,985 | |
| Shares (Diluted) | 24,497,973 | 20,431,400 | 18,232,422 | 17,531,274 | 10,189,844 | 10,836,122 | |
| EBITDA | $-8M | $-14M | $-2M | $-28M | $-35M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $24M | $20M | $27M | $32M | $49M | $8M | |
| Receivables | $30M | $10M | $15M | $28M | $23M | $24M | |
| Inventory | $10M | $14M | $10M | $14M | $10M | $1M | |
| Prepaid Expense | $3M | $3M | $4M | $3M | $2M | $2M | |
| Current Assets | $67M | $48M | $56M | $78M | $84M | $35M | |
| PP&E (Gross) | · | · | · | · | · | $11.0K | |
| Accum. Depreciation | · | · | · | · | · | $11.0K | |
| Intangibles | $28M | $32M | $20M | $27M | $13M | $15M | |
| Other Non-current Assets | · | · | $6.0K | $95.0K | $150.0K | $6.0K | |
| Total Assets | $95M | $80M | $77M | $105M | $97M | $52M | |
| Accounts Payable | $9M | $16M | $18M | $37M | $23M | $2M | |
| Accrued Liabilities | $28M | $17M | $20M | $19M | $23M | $21M | |
| Current Liabilities | $37M | $35M | $42M | $67M | $52M | $28M | |
| Capital Leases | $18.0K | $118.0K | $9.0K | $108.0K | · | $97.0K | |
| Total Liabilities | $63M | $60M | $56M | $88M | $55M | $42M | |
| Long-term Debt | $25M | $25M | $15M | $28M | · | · | |
| Total Debt | $25M | $25M | $15M | $20M | · | · | |
| Paid-in Capital | $130M | $107M | $93M | $85M | $81M | $5M | |
| Retained Earnings | $-98M | $-87M | $-72M | $-69M | $-39M | $5M | |
| Stockholders' Equity | $32M | $20M | $20M | $17M | $42M | $10M | |
| Liabilities + Equity | $95M | $80M | $77M | $105M | $97M | $52M | |
| Shares Outstanding | · | · | · | · | 11,316,344 | 3,151,333 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | $0 | $5.0K | |
| Stock-based Comp | $6M | $6M | $3M | $4M | $2M | $153.0K | |
| Deferred Tax | · | · | · | · | $2M | $-335.0K | |
| Amort. of Intangibles | $4M | $3M | $4M | $4M | $2M | $1M | |
| Other Non-cash | · | · | · | · | $38M | · | |
| Operating Cash Flow | $-12M | $-9M | $5M | $-14M | $-2M | $5M | |
| CapEx | · | $15M | $5M | $20M | · | · | |
| Investing Cash Flow | · | $-15M | $-5M | $-20M | $-10M | $-1M | |
| Stock Issued | $16M | $8M | $4M | · | $33M | · | |
| Net Stock Activity | $16M | $8M | · | · | $33M | · | |
| Financing Cash Flow | $16M | $17M | $-5M | $16M | $53M | $-487.0K | |
| Net Change in Cash | $4M | $-7M | $-5M | $-17M | $41M | $3M | |
| Taxes Paid | $50.0K | $125.0K | $181.0K | $168.0K | $158.0K | $110.0K | |
| Free Cash Flow | · | $-24M | $240.0K | $-34M | · | · | |
| Levered FCF | · | · | $-2M | $-36M | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -13.2% | -24.4% | -2.6% | -37.4% | -55.2% | · | |
| Net Margin | -18.5% | -26.1% | -4.9% | -40.2% | -69.7% | · | |
| Pretax Margin | -18.4% | -26.0% | -4.6% | -40.1% | -67.1% | · | |
| EBITDA Margin | -13.2% | -24.4% | -2.6% | -37.4% | -55.2% | · | |
| ROA | -13.1% | -18.7% | -4.2% | -29.3% | -59.0% | · | |
| ROE | -44.7% | -94.7% | -20.4% | -137.3% | -290.1% | · | |
| ROIC | -14.4% | -30.6% | -6.3% | -74.9% | -86.2% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 1.4 | 1.3 | 1.2 | 1.6 | · | |
| Quick Ratio | 1.4 | 0.9 | 1.0 | 0.9 | 1.4 | · | |
| Debt / Equity | 0.8 | 1.2 | 0.7 | 1.2 | · | · | |
| LT Debt / Equity | 0.8 | 1.2 | 0.7 | 1.2 | · | · | |
| Interest Coverage | · | · | -1.2 | -13.6 | -5.0 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.7 | 0.9 | 0.7 | 0.8 | · | |
| Inventory Turnover | 1.7 | 1.7 | 2.2 | 2.6 | 5.7 | · | |
| Receivables Turnover | 3.1 | 4.4 | 3.6 | 2.9 | 2.7 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue / Share | $2.52 | $2.75 | · | $4.20 | $6.20 | · | |
| Cash Flow / Share | $-0.51 | $-0.45 | · | $-0.77 | $-0.21 | · | |
| EPS (TTM) | $-0.47 | $-0.72 | $-0.21 | $-1.69 | $-4.32 | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.2% | -29.1% | 7.5% | 16.7% | 41.8% | · | |
| Revenue CAGR 3Y | -5.7% | -3.8% | 21.1% | · | · | · | |
| Revenue CAGR 5Y | 6.8% | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $62M | $56M | $79M | $74M | $63M | · | |
| Net Income TTM | $-11M | $-15M | $-4M | $-30M | $-44M | · | |
| P/E | -16.4 | -5.4 | -27.4 | -1.1 | -1.2 | · | |
| Earnings Yield | -6.1% | -18.4% | -3.6% | -88.0% | -80.3% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $19M | $16M | $16M | $18M | $15M | $13M | $14M | $15M | $15M | $13M | $15M | $35M | $17M | $12M | $16M | $16M | |
| Cost of Revenue | $6M | $6M | · | · | $5M | $5M | $2M | $5M | $7M | $7M | $2M | $6M | $8M | $6M | $8M | $7M | |
| R&D Expense | $54.0K | · | $154.0K | $287.0K | $0 | $39.0K | $218.0K | $842.0K | $913.0K | $8M | $2M | $2M | $2M | $2M | $4M | $3M | |
| SG&A Expense | $11M | $10M | $10M | $12M | $12M | $11M | $10M | $11M | $10M | $8M | $10M | $9M | $12M | $13M | $14M | $16M | |
| Operating Expenses | $18M | $17M | $17M | $19M | $18M | $16M | $11M | $18M | $18M | $23M | $17M | $17M | $25M | $22M | $26M | $26M | |
| Operating Income | $456.0K | $-1M | $-443.0K | $-2M | $-3M | $-3M | $2M | $-3M | $-3M | $-10M | $-2M | $17M | $-8M | $-10M | $-10M | $-9M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $548.0K | · | $268.0K | $756.0K | $650.0K | $617.0K | $559.0K | |
| Other Non-op | $-753.0K | $-738.0K | $-804.0K | $-786.0K | $-860.0K | $-749.0K | $-652.0K | $504.0K | $-434.0K | $-352.0K | $87.0K | $-361.0K | $-710.0K | $-575.0K | $-634.0K | $-578.0K | |
| Pretax Income | $-297.0K | $-2M | $-1M | $-2M | $-4M | $-4M | $2M | $-2M | $-3M | $-10M | $-2M | $17M | $-8M | $-10M | $-11M | $-10M | |
| Income Tax | $15.0K | · | $0 | $0 | $60.0K | · | · | · | · | · | $126.0K | $95.0K | · | · | $13.0K | $10.0K | |
| Net Income | $-312.0K | $-2M | $-1M | $-2M | $-4M | $-4M | $2M | $-2M | $-3M | $-10M | $-2M | $17M | $-8M | $-10M | $-11M | $-10M | |
| EPS (Basic) | $-0.01 | $-0.08 | $-0.04 | $-0.09 | $-0.16 | $-0.18 | $0.10 | $-0.12 | $-0.17 | $-0.53 | $-0.09 | $0.91 | $-0.46 | $-0.57 | $-0.61 | $-0.57 | |
| EPS (Diluted) | $-0.01 | $-0.08 | $-0.04 | $-0.09 | $-0.16 | $-0.18 | $0.10 | $-0.12 | $-0.17 | $-0.53 | $0.02 | $0.80 | $-0.46 | $-0.57 | $-0.61 | $-0.57 | |
| Shares (Basic) | 27,493,693 | 27,305,028 | · | 24,959,114 | 23,290,806 | 22,611,040 | · | 20,537,794 | 19,993,858 | 19,757,449 | · | 18,416,368 | 18,005,055 | 17,807,194 | · | 17,618,064 | |
| Shares (Diluted) | 27,493,693 | 27,305,028 | · | 24,959,114 | 23,290,806 | 22,611,040 | · | 20,537,794 | 19,993,858 | 19,757,449 | · | 21,034,758 | 18,005,055 | 17,807,194 | · | 17,618,064 | |
| EBITDA | $456.0K | $-1M | · | $-2M | $-3M | $-3M | · | $-3M | $-3M | $-10M | · | $17M | $-8M | $-10M | · | $-9M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $26M | $27M | $24M | $25M | $20M | $21M | $20M | $22M | $24M | $24M | $27M | $25M | $8M | $17M | $32M | $35M | |
| Receivables | $36M | $25M | $30M | $18M | $16M | $18M | $10M | $11M | $10M | $10M | $15M | $8M | $17M | $28M | $28M | $29M | |
| Inventory | $8M | $9M | $10M | $12M | $13M | $12M | $14M | $12M | $10M | $11M | $10M | $11M | $12M | $13M | $14M | $15M | |
| Prepaid Expense | $3M | $3M | $3M | $2M | $2M | $2M | $3M | $1M | $2M | $3M | $4M | $924.0K | $2M | $2M | $3M | $942.0K | |
| Current Assets | $73M | $65M | $67M | $56M | $51M | $54M | $48M | $46M | $46M | $47M | $56M | $45M | $48M | $61M | $78M | $80M | |
| Intangibles | $26M | $26M | $28M | $29M | $30M | $31M | $32M | $18M | $19M | $19M | $20M | $21M | $22M | $26M | $27M | $28M | |
| Other Non-current Assets | · | · | · | · | · | · | · | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $88.0K | $95.0K | $103.0K | |
| Total Assets | $98M | $92M | $95M | $85M | $81M | $85M | $80M | $64M | $65M | $67M | $77M | $66M | $70M | $96M | $105M | $108M | |
| Accounts Payable | $8M | $8M | $9M | $12M | $13M | $14M | $16M | $15M | $15M | $15M | $18M | $28M | $32M | $44M | $37M | $34M | |
| Accrued Liabilities | $32M | $26M | $28M | $21M | $23M | $23M | $17M | $16M | $16M | $20M | $20M | $16M | $23M | $17M | $19M | $18M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Current Liabilities | $46M | $38M | $37M | $40M | $40M | $40M | $35M | $33M | $34M | $39M | $42M | $49M | $68M | $77M | $67M | $61M | |
| Capital Leases | · | · | $18.0K | $44.0K | $69.0K | $94.0K | $118.0K | · | · | · | $9.0K | $34.0K | $59.0K | $84.0K | $108.0K | · | |
| Total Liabilities | $66M | $61M | $63M | $59M | $62M | $63M | $60M | $53M | $54M | $54M | $56M | $49M | $70M | $88M | $88M | $82M | |
| Long-term Debt | $25M | $25M | $25M | $25M | $25M | $25M | $25M | $20M | $20M | $15M | $15M | $0 | $10M | $23M | $28M | · | |
| Total Debt | $25M | $25M | · | $25M | $25M | $25M | · | $20M | $20M | $15M | · | · | $10M | $20M | · | $20M | |
| Paid-in Capital | $133M | $132M | $130M | $123M | $114M | $113M | $107M | $99M | $97M | $96M | $93M | $88M | $87M | $86M | $85M | $84M | |
| Retained Earnings | $-101M | $-101M | $-98M | $-97M | $-95M | $-91M | $-87M | $-89M | $-86M | $-83M | $-72M | $-70M | $-87M | $-79M | $-69M | $-58M | |
| Stockholders' Equity | $32M | $31M | $32M | $26M | $19M | $22M | $20M | $11M | $11M | $13M | $20M | $17M | $5.0K | $7M | $17M | $26M | |
| Liabilities + Equity | $98M | $92M | $95M | $85M | $81M | $85M | $80M | $64M | $65M | $67M | $77M | $66M | $70M | $96M | $105M | $108M |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $989.0K | $2M | $2M | $1M | $1M | $1M | $2M | $2M | $1M | $529.0K | $558.0K | $873.0K | $646.0K | $1M | $1M | |
| Amort. of Intangibles | $969.0K | $1M | $1M | $1M | $1M | $1M | $982.0K | $814.0K | $814.0K | $814.0K | $815.0K | $814.0K | $1M | $1M | $1M | $1M | |
| Operating Cash Flow | $-2M | $3M | $-6M | $-2M | $-942.0K | $-3M | $2M | $-1M | $-5M | $-5M | $-17M | $19M | $4M | $-956.0K | $-4M | $-7M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $5M | $0 | $0 | |
| Investing Cash Flow | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $-5M | $0 | $0 | |
| Stock Issued | · | · | $5M | $7M | $0 | $4M | $6M | $194.0K | $0 | $1M | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $4M | · | · | · | $1M | · | · | · | · | · | · | |
| Financing Cash Flow | $158.0K | $220.0K | $5M | $7M | $165.0K | $4M | $11M | $-294.0K | $5M | $2M | $19M | $-11M | $-13M | $52.0K | $948.0K | $4M | |
| Net Change in Cash | $-2M | $3M | $-858.0K | $5M | $-777.0K | $765.0K | $-2M | $-1M | $-145.0K | $-3M | $3M | $8M | $-9M | $-6M | $-3M | $-3M | |
| Taxes Paid | · | · | $1.0K | $0 | · | · | $21.0K | $1.0K | · | · | $96.0K | $0 | $78.0K | $7.0K | $149.0K | · | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-6M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.5% | -9.3% | · | -8.7% | -19.2% | -25.3% | · | -19.8% | -19.7% | -77.4% | · | 49.9% | -44.6% | -78.3% | · | -58.9% | |
| Net Margin | -1.7% | -14.0% | · | -13.1% | -25.3% | -31.0% | · | -16.3% | -22.6% | -80.1% | · | 48.6% | -48.7% | -83.0% | · | -62.5% | |
| Pretax Margin | -1.6% | -14.0% | · | -13.1% | -24.9% | -31.0% | · | -16.3% | -22.6% | -80.1% | · | 48.9% | -48.7% | -83.0% | · | -62.5% | |
| EBITDA Margin | 2.5% | -9.3% | · | -8.7% | -19.2% | -25.3% | · | -19.8% | -19.7% | -77.4% | · | 49.9% | -44.6% | -78.3% | · | -58.9% | |
| ROA | -0.35% | -2.5% | · | -3.1% | -5.2% | -5.4% | · | -3.7% | -5.0% | -12.9% | · | 19.3% | -9.1% | -9.3% | · | -10.2% | |
| ROE | -1.2% | -8.5% | · | -12.6% | -24.9% | -23.6% | · | -16.9% | -59.5% | -102.2% | · | 77.1% | -48.1% | -41.4% | · | -139.3% | |
| ROIC | 0.83% | · | · | · | -6.6% | · | · | · | · | · | · | 98.7% | · | · | · | -20.7% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 1.7 | · | 1.4 | 1.3 | 1.3 | · | 1.4 | 1.4 | 1.2 | · | 0.9 | 0.7 | 0.8 | · | 1.3 | |
| Quick Ratio | 1.4 | 1.4 | · | 1.1 | 0.9 | 1.0 | · | 1.0 | 1.0 | 0.9 | · | 0.7 | 0.4 | 0.6 | · | 1.0 | |
| Debt / Equity | 0.8 | 0.8 | · | 1.0 | 1.3 | 1.2 | · | 1.8 | 1.7 | 1.1 | · | · | 1988.4 | 2.6 | · | 0.8 | |
| LT Debt / Equity | 0.6 | 0.7 | · | 0.8 | 1.1 | 1.1 | · | 1.8 | 1.7 | 1.1 | · | · | · | 1.3 | · | 0.8 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -18.4 | · | 64.3 | -10.1 | -14.7 | · | -17.0 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.4 | 0.2 | 0.1 | · | 0.2 | |
| Inventory Turnover | 0.6 | 0.6 | · | · | · | · | · | 0.5 | 0.6 | 0.6 | · | 0.5 | 0.6 | 0.4 | · | 0.5 | |
| Receivables Turnover | 0.7 | 0.7 | · | 1.2 | 1.1 | 0.9 | · | 1.6 | 1.1 | 0.7 | · | 1.9 | 0.8 | 0.4 | · | 0.5 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $0.67 | $0.58 | · | $0.71 | $0.64 | $0.58 | · | $0.71 | $0.74 | $0.66 | · | $1.64 | $0.95 | $0.69 | · | $0.91 | |
| Cash Flow / Share | · | $0.11 | · | · | · | $-0.13 | · | · | · | $-0.25 | · | · | · | $-0.05 | · | · | |
| EPS (TTM) | $-0.22 | $-0.37 | · | $-0.33 | $-0.36 | $-0.37 | · | $-0.80 | $0.12 | $-0.17 | · | $-0.84 | $-2.21 | $-2.18 | · | $-2.96 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $68M | $65M | · | $59M | $56M | $56M | · | $58M | $78M | $80M | · | $80M | $61M | $63M | · | $75M | |
| Net Income TTM | $-6M | $-10M | · | $-9M | $-9M | $-8M | · | $-18M | $843.0K | $-4M | · | $-12M | $-39M | $-38M | · | $-41M | |
| P/E | -32.2 | -12.7 | · | -21.6 | -19.9 | -15.9 | · | -7.1 | 47.0 | -21.6 | · | -3.3 | -0.7 | -0.7 | · | -0.8 | |
| Earnings Yield | -3.1% | -7.9% | · | -4.6% | -5.0% | -6.3% | · | -14.2% | 2.1% | -4.6% | · | -30.7% | -139.0% | -138.8% | · | -120.3% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $62M | $56M | $79M | $74M | $63M |
| Betriebsgewinnmarge % | -13.2% | -24.4% | -2.6% | -37.4% | -55.2% |
| Nettoergebnis | $-11M | $-15M | $-4M | $-30M | $-44M |
| Verwässerte EPS | $-0.47 | $-0.72 | $-0.21 | $-1.69 | $-4.32 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.8 | 1.2 | 0.7 | 1.2 | · |
| Liquiditätsgrad | 1.8 | 1.4 | 1.3 | 1.2 | 1.6 |
| Quick Ratio | 1.4 | 0.9 | 1.0 | 0.9 | 1.4 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | · | $-24M | $240.0K | $-34M | · |
Institutionelle Eigentümer (13F) 75 Einreicher · $72.0M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
75
Gehaltener Wert
$72.0M
Neue Positionen
25
Geschlossene Positionen
23
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 25 (+10 vs. Vorquartal) | 23 (+8 vs. Vorquartal) | 17 (-14 vs. Vorquartal) | 23 (+6 vs. Vorquartal) | -4.1M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | $11.398.800 | 1.610.000 | 15,83% | Aktien |
| WASATCH ADVISORS LP | $10.005.505 | 2.133.370 | 13,90% | Aktien |
| VANGUARD GROUP INC | $5.891.574 | 764.147 | 8,18% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $4.780.310 | 675.185 | 6,64% | Aktien |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | $3.794.880 | 536.000 | 5,27% | Aktien |
| Pale Fire Capital SE | $3.742.375 | 528.584 | 5,20% | Aktien |
| Opaleye Management Inc. | $2.478.000 | 350.000 | 3,44% | Aktien |
| Summit Financial, LLC | $2.454.976 | 346.748 | 3,41% | Aktien |
| JANE STREET GROUP, LLC | $2.265.749 | 320.021 | 3,15% | Aktien |
| Diametric Capital, LP | $2.093.294 | 295.663 | 2,91% | Aktien |
| Ikarian Capital, LLC | $1.780.168 | 251.436 | 2,47% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $1.626.276 | 229.700 | 2,26% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $1.530.115 | 216.004 | 2,13% | Aktien |
| AMERICAN FINANCIAL GROUP INC | $1.274.400 | 180.000 | 1,77% | Aktien |
| Trexquant Investment LP | $1.213.073 | 171.338 | 1,69% | Aktien |
| MARSHALL WACE, LLP | $990.087 | 139.843 | 1,38% | Aktien |
| J. Goldman & Co LP | $974.095 | 137.584 | 1,35% | Aktien |
| Sheets Smith Investment Management | $946.276 | 132.904 | 1,31% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $778.913 | 110.016 | 1,08% | Aktien |
| BlackRock, Inc. | $714.945 | 100.981 | 0,99% | Aktien |
| XTX Topco Ltd | $714.535 | 100.923 | 0,99% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $670.681 | 94.729 | 0,93% | Aktien |
| GOLDMAN SACHS GROUP INC | $639.282 | 90.294 | 0,89% | Aktien |
| UBS Group AG | $591.279 | 83.514 | 0,82% | Aktien |
| CITADEL ADVISORS LLC | $581.615 | 82.149 | 0,81% | Aktien |
| PVG ASSET MANAGEMENT CORP | $563.377 | 79.573 | 0,78% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $477.489 | 67.442 | 0,66% | Aktien |
| STATE STREET CORP | $467.124 | 65.978 | 0,65% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $466.041 | 65.825 | 0,65% | Aktien |
| Walleye Capital LLC | $463.471 | 65.462 | 0,64% | Aktien |
| Geneos Wealth Management Inc. | $448.022 | 63.280 | 0,62% | Aktien |
| Frec Markets, Inc. | $357.540 | 50.500 | 0,50% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $335.670 | 47.411 | 0,47% | Aktien |
| Squarepoint Ops LLC | $321.467 | 45.405 | 0,45% | Aktien |
| MORGAN STANLEY | $297.530 | 42.024 | 0,41% | Aktien |
| BANK OF AMERICA CORP /DE/ | $296.701 | 41.907 | 0,41% | Aktien |
| Integrated Wealth Concepts LLC | $280.212 | 39.578 | 0,39% | Aktien |
| ADAR1 Capital Management, LLC | $279.780 | 39.517 | 0,39% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $254.200 | 35.904 | 0,35% | Aktien |
| NORTHERN TRUST CORP | $252.444 | 35.656 | 0,35% | Aktien |
| Aster Capital Management (DIFC) Ltd | $217.498 | 30.720 | 0,30% | Aktien |
| SALEM INVESTMENT COUNSELORS INC | $206.736 | 29.200 | 0,29% | Aktien |
| Quadrature Capital Ltd | $204.194 | 28.841 | 0,28% | Aktien |
| JANE STREET GROUP, LLC | $201.072 | 28.400 | 0,28% | Kaufoption |
| AQR CAPITAL MANAGEMENT LLC | $176.129 | 24.877 | 0,24% | Aktien |
| PRELUDE CAPITAL MANAGEMENT, LLC | $155.087 | 21.905 | 0,22% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $141.607 | 20.001 | 0,20% | Aktien |
| Gladstone Institutional Advisory LLC | $141.600 | 20.000 | 0,20% | Aktien |
| Brevan Howard Capital Management LP | $133.508 | 18.857 | 0,19% | Aktien |
| Invesco Ltd. | $118.087 | 16.679 | 0,16% | Aktien |
Unternehmensinsider 11 Insider · 4 Führungskräfte · 7 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Claude Maraoui | President & CEO | 22. April 2026 A | 2.435.990 | 0 | 0 | $0 |
| Joseph Benesch | CFO | 22. April 2026 A | 261.371 | 0 | 0 | $0 |
| Ernest Robert De Paolantonio | As of the date of the original Form 4 filed on October 6, 2022, the Reporting Person was the Chief Financial Officer of the Issu | 4. Oktober 2022 S | 259.907 | 0 | 0 | $0 |
| Ramsey Alloush | Chief Operating Officer | 22. April 2026 A | 598.543 | 0 | 0 | $0 |
| Justin Adam Smith | Direktor | 1. Juli 2026 A | 231.618 | 0 | 0 | $0 |
| Miranda Jayne Toledano | Direktor | 1. Juli 2026 A | 168.618 | 0 | 0 | $0 |
| Neil Herskowitz | Direktor | 1. Juli 2026 A | 168.618 | 0 | 0 | $0 |
| Michael Cooper Pearce | Direktor | 25. Juni 2026 A | 67.173 | 0 | 0 | $0 |
| Lindsay A. Rosenwald, M.D. | Direktor | 25. Juni 2026 A | 221.146 | 0 | 0 | $0 |
| Jeffrey Paley | Direktor | 8. November 2023 S | 114.217 | 0 | 0 | $0 |
| Fortress Biotech, Inc. | 10%-Eigentümer | 12. Mai 2023 J | 3.860.467 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 4 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,48% | 16.187 SH | 1. Oktober 2026 | Täglich |
| IWC · iShares Trust | 0,03% | 50.596 SH | 11. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 186.966 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 470.426 SH | 19. August 2026 | Täglich |
DERM Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 10 Analysten
KAUF
Median-Ziel
$13.50
+104,2%
2 20,0%
Starker Kauf
7 70,0%
Kauf
1 10,0%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
4 Analysten · 2026-09-29Mittelwert-Ziel $13.75 +108,0%
← Unter allen Zielen
Aktueller Preis $6.61
Tief$13.00
Mittelwert$13.75
Hoch$15.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 12, 2026